Follow the latest coverage, related explainers and connected technology stories.
Stryker and Zimmer Biomet believe the new Medicare model for joint replacement surgeries will not put much pressure on implant prices, while an analyst warns that medical device companies may have to demonstrate the technological impact of their products in reducing readmissions and emergency visits.